Clinical Practice Guideline: Bell's Palsy

Otolaryngology-Head and Neck Surgery

Volumn 149, Issue , 2013, Pages S1-S27

  Baugh, Reginald F ^a   Basura, Gregory J ^b   Ishii, Lisa E ^c   Schwartz, Seth R ^d   Drumheller, Caitlin Murray ^e   Burkholder, Rebecca ^f   Deckard, Nathan A ^g   Dawson, Cindy ^h   Driscoll, Colin ⁱ   Gillespie, M Boyd ^j   Gurgel, Richard K ^k   Halperin, John ^l   Khalid, Ayesha N ^m,n   Kumar, Kaparaboyna Ashok ^o   Micco, Alan ^p   Munsell, Debra ^q   Rosenbaum, Steven ^r   Vaughan, William ^s  

^a UNIVERSITY OF TOLEDO MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d VIRGINIA MASON MEDICAL CENTER   (United States)

^e AMERICAN ACADEMY OF OTOLARYNGOLOGY   (United States)

^f National Consumers League   (United States)

^g Department of Urology   (United States)

^h UNIVERSITY OF IOWA   (United States)

ⁱ MAYO CLINIC   (United States)

^j MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^k UNIVERSITY OF UTAH   (United States)

^l Overlook Medical Center   (United States)

^m EMERSON HOSPITAL   (United States)

ⁿ HARVARD MEDICAL SCHOOL   (United States)

^o UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^p NORTHWESTERN UNIVERSITY   (United States)

^q LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^r Mountainside Hospital   (United States)

^s National Committee to Preserve Social Security and Medicare   (United States)

more..

Author keywords

Bell's palsy; facial nerve disorder; facial nerve pathophysiology; idiopathic facial nerve paralysis; idiopathic facial nerve paresis; otolaryngology

Indexed keywords

ANTIVIRUS AGENT; STEROID;

ARTICLE; BELL PALSY; CLINICAL FEATURE; DIAGNOSTIC IMAGING; ECONOMIC ASPECT; ELECTRODIAGNOSIS; ELECTROMYOGRAPHY; ELECTRONEUROGRAPHY; EVIDENCE BASED MEDICINE; EYE CARE; FACIAL NERVE PARALYSIS; FOLLOW UP; HEALTH CARE; HUMAN; LABORATORY TEST; LYME DISEASE; MEDICAL HISTORY; MONOTHERAPY; NONHUMAN; PHYSICAL EXAMINATION; PHYSIOTHERAPY; PRACTICE GUIDELINE; DISEASE MANAGEMENT; MEDICAL SOCIETY; OTORHINOLARYNGOLOGY; PROCEDURES; UNITED STATES;

BELL PALSY; DISEASE MANAGEMENT; HUMANS; OTOLARYNGOLOGY; SOCIETIES, MEDICAL; UNITED STATES;

EID: 84899786383     PISSN: 01945998     EISSN: 10976817     Source Type: Journal    
DOI: 10.1177/0194599813505967     Document Type: Article

References (148)

1. Peitersen E. Bell's palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies. Acta Otolaryngol Supplement 2002;(549):4-30.
2. Lockhart P, Daly F, Pitkethly M, Comerford N Sullivan F. Antiviral treatment for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev. 2009;(4):CD001869.
3. Salinas RA, Alvarez G, Daly F Ferreira J. Corticosteroids for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev. 2010;(3):CD001942.
4. Linder TE, Abdelkafy W, Cavero-Vanek S. The management of peripheral facial nerve palsy: “paresis” versus “paralysis” and sources of ambiguity in study designs. Otol Neurotol. 2010; 31: 319-327.
5. Fisch U. Surgery for Bell's palsy. Arch Otolaryngol. 1981; 107: 1-11.
6. Adour K, Wingerd J, Doty HE. Prevalence of concurrent diabetes mellitus and idiopathic facial paralysis (Bell's palsy). Diabetes. 1975; 24: 449-451.
7. Adour KK, Bell DN, Hilsinger RL Jr. Herpes simplex virus in idiopathic facial paralysis (Bell palsy). JAMA. 1975; 233: 527-530.
8. Gantz BJ, Rubinstein JT, Gidley P Woodworth GG. Surgical management of Bell's palsy. Laryngoscope. 1999; 109: 1177-1188.
9. Piercy J. Bell's palsy. BMJ. 2005; 330: 1374.
10. Ahmed A. When is facial paralysis Bell palsy? Current diagnosis and treatment. Cleve Clin J Med. 2005; 72: 398-401, 405.
11. Song MH, Kim J, Jeon JH, et al. Clinical significance of quantitative analysis of facial nerve enhancement on MRI in Bell's palsy. Acta Otolaryngol. 2008; 128: 1259-1265.
12. Sittel C, Stennert E. Prognostic value of electromyography in acute peripheral facial nerve palsy. Otol Neurotol. 2001; 22: 100-104.
13. Gilden DH. Clinical practice. Bell's palsy. N Engl J Med. 2004; 351: 1323-1331.
14. Kim YH, Choi IJ, Kim HM, Ban JH, Cho CH Ahn JH. Bilateral simultaneous facial nerve palsy: clinical analysis in seven cases. Otol Neurotol. 2008; 29: 397-400.
15. Liu J, Li Y, Yuan X Lin Z. Bell's palsy may have relations to bacterial infection. Med Hypotheses. 2009; 72: 169-170.
16. Morgan M, Moffat M, Ritchie L, Collacott I Brown T. Is Bell's palsy a reactivation of varicella zoster virus? J Infect. 1995; 30: 29-36.
17. Unlu Z, Aslan A, Ozbakkaloglu B, Tunger O Surucuoglu S. Serologic examinations of hepatitis, cytomegalovirus, and rubella in patients with Bell's palsy. Am J Phys Med Rehabil. 2003; 82: 28-32.
18. Adour KK, Byl FM, Hilsinger RL Jr Kahn ZM Sheldon MI. The true nature of Bell's palsy: analysis of 1,000 consecutive patients. Laryngoscope. 1978; 88: 787-801.
19. Engstrom M, Jonsson L, Grindlund M Stalberg E. House-Brackmann and Yanagihara grading scores in relation to electroneurographic results in the time course of Bell's palsy. Acta Otolaryngol. 1998; 118: 783-789.
20. House JW, Brackmann DE. Facial nerve grading system. Otolaryngol Head Neck Surg. 1985; 93: 146-147.
21. Peitersen E. Natural history of Bell's palsy. Acta Otolaryngol Supplement 1992; 492: 122-124.
22. Berg T, Axelsson S, Engstrom M, et al. The course of pain in Bell's palsy: treatment with prednisolone and valacyclovir. Otol Neurotol. 2009; 30: 842-846.
23. Engstrom M, Berg T, Stjernquist-Desatnik A, et al. Prednisolone and valaciclovir in Bell's palsy: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet Neurol. 2008; 7: 993-1000.
24. Mechelse K, Goor G, Huizing EH, et al. Bell's palsy: prognostic criteria and evaluation of surgical decompression. Lancet. 1971; 2: 57-59.
25. Valente SM. Visual disfigurement and depression. Plast Surg Nurs. 2004; 24: 140-148.
26. Miwa H, Kondo T, Mizuno Y. Bell's palsy-induced blepharospasm. J Neurol. 2002; 249: 452-454.
27. Bracewell RM. The treatment of Bell's palsy. N Engl J Med. 2007; 357: 1598-1607.
28. Lyons CJ, McNab AA. Symptomatic nocturnal lagophthalmos. Aust N Z J Ophthalmol. 1990; 18: 393-396.
29. Hayashi A, Maruyama Y, Okada E Ogino A. Use of a suture anchor for correction of ectropion in facial paralysis. Plast Reconstr Surg. 2005; 115: 234-239.
30. Ramakrishnan Y, Alam S, Kotecha A, Gillett D D’Souza A. Reanimation following facial palsy: present and future directions. J Laryngol Otol. 2010; 124: 1146-1152.
31. Brandenburg NA, Annegers JF. Incidence and risk factors for Bell's palsy in Laredo, Texas: 1974-1982. Neuroepidemiology. 1993; 12: 313-325.
32. Katusic SK, Beard CM, Wiederholt WC, Bergstralh EJ Kurland LT. Incidence, clinical features, and prognosis in Bell's palsy, Rochester, Minnesota, 1968-1982. Ann Neurol. 1986; 20: 622-627.
33. Monini S, Lazzarino AI, Iacolucci C, Buffoni A Barbara M. Epidemiology of Bell's palsy in an Italian Health District: incidence and case-control study. Acta Otorhinolaryngol Ital. 2010; 30: 198.
34. Rowlands S, Hooper R, Hughes R Burney P. The epidemiology and treatment of Bell's palsy in the UK. Eur J Neurol. 2002; 9: 63-67.
35. Tsai HS, Chang LY, Lu CY, et al. Epidemiology and treatment of Bell's palsy in children in northern Taiwan. J Microbiol Immunol Infect. 2009; 42: 351-356.
36. Lunan R, Nagarajan L. Bell's palsy: a guideline proposal following a review of practice. J Paediatr Child Health. 2008; 44: 219-220.
37. Rowhani-Rahbar A Baxter R Rasgon B, et al. Epidemiologic and clinical features of Bell's palsy among children in Northern California. Neuroepidemiology. 2012; 38: 252-258.
38. Katz A, Sergienko R, Dior U, Wiznitzer A, Kaplan DM Sheiner E. Bell's palsy during pregnancy: is it associated with adverse perinatal outcome? Laryngoscope. 2011; 121: 1395-1398.
39. Savadi-Oskouei D Abedi A Sadeghi-Bazargani H. Independent role of hypertension in Bell's palsy: a case-control study. Eur Neurol. 2008; 60: 253-257.
40. Byrne PJ. Importance of facial expression in facial nerve rehabilitation. Curr Opin Otolaryngol Head Neck Surg. 2004; 12: 332-335.
41. Ishii L, Godoy A, Encarnacion CO, Byrne PJ, Boahene KD Ishii M. Not just another face in the crowd: society's perceptions of facial paralysis. Laryngoscope. 2012; 122: 533-538.
42. Rosenfeld RM, Shiffman RN, Robertson P. Clinical practice guideline development manual, third edition: a quality-driven approach for translating evidence into action. Otolaryngol Head Neck Surg. 2013; 148(1)(Supplement):S1-S55.
43. Shiffman RN, Shekelle P, Overhage JM, Slutsky J, Grimshaw J Deshpande AM. Standardized reporting of clinical practice guidelines: a proposal from the Conference on Guideline Standardization. Ann Intern Med. 2003; 139: 493-498.
44. Shiffman RN, Dixon J, Brandt C, et al. The GuideLine Implementability Appraisal (GLIA): development of an instrument to identify obstacles to guideline implementation. BMC Med Inform Decis Making. 2005; 5: 23.
45. Classifying recommendations for clinical practice guidelines. Pediatrics. 2004; 114: 874-877.
46. Centre for Evidence Based Medicine. The Oxford 2011 Levels of Evidence. 2001. http://www.cebm.net/index.aspx?o=5653
47. Choudhry NK, Stelfox HT, Detsky AS. Relationships between authors of clinical practice guidelines and the pharmaceutical industry. JAMA. 2002; 287: 612-617.
48. Detsky AS. Sources of bias for authors of clinical practice guidelines. CMAJ. 2006; 175: 1033, 1035.
49. Yanagihara N. Incidence of Bell's palsy. Ann Otol Rhinol Laryngol Supplement 1988; 137: 3-4.
50. Tiemstra JD, Khatkhate N. Bell's palsy: diagnosis and management. Am Fam Physician. 2007; 76: 997-1002.
51. May M, Schaitkin BM. Tumors involving the facial nerve. In: The Facial Nerve. 2nd ed. New York, NY: Thieme; 2000.
52. Halperin JJ, Golightly M. Lyme borreliosis in Bell's palsy. Long Island Neuroborreliosis Collaborative Study Group. Neurology. 1992; 42: 1268-1270.
53. Centers for Disease Control and Prevention. Lyme disease data. 2012. http://www.cdc.gov/lyme/stats/index.html. Accessed March 27, 2013.
54. Holland J. Bell's palsy. Clin Evid (Online). 2008; 2008: 1204.
55. Kinoshita T, Ishii K, Okitsu T, Okudera T Ogawa T. Facial nerve palsy: evaluation by contrast-enhanced MR imaging. Clin Radiol. 2001; 56: 926-932.
56. Mahoney E, Agarwal S, Li B, et al. Evidence-based guidelines are equivalent to a liberal computed tomography scan protocol for initial patient evaluation but are associated with decreased computed tomography scan use, cost, and radiation exposure. J Trauma Acute Care Surg. 2012; 73: 573-579.
57. Konen E, Konen O, Katz M, Levy Y, Rozenman J Hertz M. Are referring clinicians aware of patients at risk from intravenous injection of iodinated contrast media? Clin Radiol. 2002; 57: 132-135.
58. Thrall JH. Radiation exposure in CT scanning and risk: where are we? Radiology. 2012; 264: 325-328.
59. American College of Radiology. ACR statement on recent studies regarding CT scans and increased cancer risk. http://gm.acr.org/MainMenuCategories/media_room/FeaturedCategories/PressReleases/StatementonRecentStudiesRegardingCTScans.aspx. Accessed March 5, 2013.
60. Breadon GE, Cody DT, Weiland LH. Facial palsy: unusual etiology. Laryngoscope. 1977; 87: 26-34.
61. Gronseth GS, Paduga R. Evidence-based guideline update: steroids and antivirals for Bell palsy: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2012; 79: 2209-2213.
62. Sullivan FM, Swan IR, Donnan PT, et al. Early treatment with prednisolone or acyclovir in Bell's palsy. N Engl J Med. 2007; 357: 1598-1607.
63. KatzungBG, MastersSB, TrevorAJ, eds. Basic & Clinical Pharmacology. 12th ed. New York, NY: McGraw-Hill.
64. SweetmanSC, ed. Martindale: The Complete Drug Reference. 34th ed. London, UK: Pharmaceutical Press; 2004.
65. Pitaro J, Waissbluth S, Daniel SJ. Do children with Bell's palsy benefit from steroid treatment? A systematic review. Int J Pediatr Otorhinolaryngol. 2012; 76: 921-926.
66. Atzema C, Goldman RD. Should we use steroids to treat children with Bell's palsy? Can Fam Physician. 2006; 52: 313-314.
67. Pitaro K, Waissbluth S, Daniel SJ. Steroids in pediatric Bell palsy: a systematic review. Otolaryngol Head Neck Surg. 2011; 145: 246.
68. Salman MS, MacGregor DL. Should children with Bell's palsy be treated with corticosteroids? A systematic review. J Child Neurol. 2001; 16: 565-568.
69. Kawaguchi K, Inamura H, Abe Y, et al. Reactivation of herpes simplex virus type 1 and varicella-zoster virus and therapeutic effects of combination therapy with prednisolone and valacyclovir in patients with Bell's palsy. Laryngoscope. 2007; 117: 147-156.
70. Alberton DL, Zed PJ. Bell's palsy: a review of treatment using antiviral agents. Ann Pharmacother. 2006; 40: 1838-1842.
71. Allen D, Dunn L. Aciclovir or valaciclovir for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev. 2004;(3):CD001869.
72. Browning GG. Bell's palsy: a review of three systematic reviews of steroid and anti-viral therapy. Clin Otolaryngol. 2010; 35: 56-58.
73. de Almeida JR Al Khabori M Guyatt GH, et al. Combined corticosteroid and antiviral treatment for Bell palsy: a systematic review and meta-analysis. JAMA. 2009; 302: 985-993.
74. Yuen MC, Crawford I. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Bell's palsy and acyclovir. Emerg Med J. 2002; 19: 326-327.
75. Axelsson S, Berg T, Jonsson L, Engstrom M, Kanerva M Stjernquist-Desatnik A. Bell's palsy—the effect of prednisolone and/or valaciclovir versus placebo in relation to baseline severity in a randomised controlled trial. Clin Otolaryngol. 2012; 37: 283-290.
76. Quant EC, Jeste SS, Muni RH, Cape AV, Bhussar MK Peleg AY. The benefits of steroids versus steroids plus antivirals for treatment of Bell's palsy: a meta-analysis. BMJ. 2009; 339: b3354.
77. Goudakos JK, Markou KD. Corticosteroids vs corticosteroids plus antiviral agents in the treatment of Bell palsy: a systematic review and meta-analysis. Arch Otolaryngol Head Neck Surg. 2009; 135: 558-564.
78. Numthavaj P, Thakkinstian A, Dejthevaporn C Attia J. Corticosteroid and antiviral therapy for Bell's palsy: a network meta-analysis. BMC Neurol. 2011; 11: 1.
79. Hato N, Yamada H, Kohno H, et al. Valacyclovir and prednisolone treatment for Bell's palsy: a multicenter, randomized, placebo-controlled study. Otol Neurotol. 2007; 28: 408-413.
80. Shahidullah M, Haque A, Islam MR, et al. Comparative study between combination of famciclovir and prednisolone with prednisolone alone in acute Bell's palsy. Mymensingh Med J. 2011; 20: 605-613.
81. Bhatti MT, Schiffman JS, Pass AF Tang RA. Neuro-ophthalmologic complications and manifestations of upper and lower motor neuron facial paresis. Curr Neurol Neurosci Rep. 2010; 10: 448-458.
82. Rosenberg JB, Eisen LA. Eye care in the intensive care unit: narrative review and meta-analysis. Crit Care Med. 2008; 36: 3151-3155.
83. Sturrock GD. Nocturnal lagophthalmos and recurrent erosion. Br J Ophthalmol. 1976; 60: 97-103.
84. Betharia SM, Sharma V. Inverse Bell's phenomenon observed following levator resection for blepharoptosis. Graefes Arch Clin Exp Ophthalmol. 2006; 244: 868-870.
85. Calder L, Balasubramanian S, Stiell I. Lack of consensus on corneal abrasion management: results of a national survey. CJEM. 2004; 6: 402-407.
86. Flynn CA, D’Amico F Smith G. Should we patch corneal abrasions? A meta-analysis. J Fam Pract. 1998; 47: 264-270.
87. What to do about Bell's palsy: recovery takes time, patience, proper eye care, and maybe a medication. Harv Womens Health Watch. 2010; 17: 5.
88. Na KS, Yang SW. Two cases of inverse Bell's phenomenon following levator resection: a contemplation of the mechanism. Eur J Ophthalmol. 2009; 19: 285-287.
89. Lorch M, Teach SJ. Facial nerve palsy: etiology and approach to diagnosis and treatment. Pediatr Emerg Care. 2010; 26: 763-773.
90. Mitchell J. Ocular emergencies: Sec. 20 emergency medicine. Tintinalli's Emergency Medicine: A Comprehensive Study Guide. New York, NY: McGraw-Hill Education; 2004.
91. Murthy JM, Saxena AB. Bell's palsy: treatment guidelines. Ann Indian Acad Neurol. 2011; 14(Supplement 1):S70-S72.
92. Rodrigues de Araujo M. Management of Bell's palsy: a report of 2 cases. J Can Dent Assoc. 2008; 74(9):823-837.
93. College of Optometrists. Facial palsy (including Bell's palsy). In: Clinical Management Guidelines. 2008. http://www.college-optometrists.org/en/utilities/document-summary.cfm/docid/63AD5CC8-EB0F-41CB-89508DC2D43560FB. Accessed February 13, 2013.
94. Turner A, Rabiu M. Patching for corneal abrasion. Cochrane Database Syst Rev. 2006;(2):CD004764.
95. Seiff SR, Chang JS, Jr. The staged management of ophthalmic complications of facial nerve palsy. Ophthal Plast Reconstr Surg. 1993; 9: 241-249.
96. Zaidi FH, Gregory-Evans K Acheson JF Ferguson V. Familial Bell's palsy in females: a phenotype with a predilection for eyelids and lacrimal gland. Orbit. 2005; 24: 121-124.
97. Adour KK, Sheldon MI, Kahn ZM. Maximal nerve excitability testing versus neuromyography: prognostic value in patients with facial paralysis. Laryngoscope. 1980; 90: 1540-1547.
98. Baba S, Kondo K, Kanaya K, Ushio M, Tojima H Yamasoba T. Bell's palsy in children: relationship between electroneurography findings and prognosis in comparison with adults. Otol Neurotol. 2011; 32: 1554-1558.
99. Sinha PK, Keith RW, Pensak ML. Predictability of recovery from Bell's palsy using evoked electromyography. Am J Otol. 1994; 15: 769-771.
100. Mantsopoulos K, Psillas G, Psychogios G, Brase C, Iro H Constantinidis J. Predicting the long-term outcome after idiopathic facial nerve paralysis. Otol Neurotol. 2011; 32: 848-851.
101. Gilliatt RW, Taylor JC. Electrical changes following section of the facial nerve. Proc R Soc Med. 1959; 53: 1080-1083.
102. Tojima H, Aoyagi M, Inamura H Koike Y. Clinical advantages of electroneurography in patients with Bell's palsy within two weeks after onset. Acta Otolaryngol Supplement 1994; 511: 147-149.
103. Sillman JS, Niparko JK, Lee SS Kileny PR. Prognostic value of evoked and standard electromyography in acute facial paralysis. Otolaryngol Head Neck Surg. 1992; 107: 377-381.
104. Grogan PM, Gronseth GS. Practice parameter: steroids, acyclovir, and surgery for Bell's palsy (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001; 56: 830-836.
105. McAllister K, Walker D, Donnan PT Swan I. Surgical interventions for the early management of Bell's palsy. Cochrane Database Syst Rev. 2011;(2):CD007468.
106. Fisch U, Esslen E. Total intratemporal exposure of the facial nerve: pathologic findings in Bell's palsy. Arch Otolaryngol. 1972; 95: 335-341.
107. Gantz BJ, Gmur A, Fisch U. Intraoperative evoked electromyography in Bell's palsy. Am J Otolaryngol. 1982; 3: 273-278.
108. Yamamoto E, Fisch U. Experimentally induced facial nerve compression in cats. Acta Otolaryngol. 1975; 79: 390-395.
109. Ge XX, Spector GJ. Labyrinthine segment and geniculate ganglion of facial nerve in fetal and adult human temporal bones. Ann Otol Rhinol Laryngol Supplement 1981; 90: 1-12.
110. Adour KK, Swanson PJ, Jr. Facial paralysis in 403 consecutive patients: emphasis on treatment response in patients with Bell's palsy. Trans Am Acad Ophthalmol Otolaryngol. 1971; 75: 1284-1301.
111. May M, Klein SR, Taylor FH. Indications for surgery for Bell's palsy. Am J Otol. 1984; 5: 503-512.
112. Aoyagi M, Koike Y, Ichige A. Results of facial nerve decompression. Acta Otolaryngol Supplement 1988; 446: 101-105.
113. Yanagihara N, Hato N, Murakami S Honda N. Transmastoid decompression as a treatment of Bell palsy. Otolaryngol Head Neck Surg. 2001; 124: 282-286.
114. Kim IS, Shin SH, Kim J, Lee WS Lee HK. Correlation between MRI and operative findings in Bell's palsy and Ramsay Hunt syndrome. Yonsei Med J. 2007; 48: 963-968.
115. Bodenez C, Bernat I, Willer JC, Barre P, Lamas G Tankere F. Facial nerve decompression for idiopathic Bell's palsy: report of 13 cases and literature review. J Laryngol Otol. 2010; 124: 272-278.
116. House WF, Shelton C. Middle fossa approach for acoustic tumor removal. Otolaryngol Clin North Am. 1992; 25: 347-359.
117. Brackmann DE, House JR, III Hitselberger WE. Technical modifications to the middle fossa craniotomy approach in removal of acoustic neuromas. Am J Otol. 1994; 15: 614-619.
118. Glasscock ME, McKennan KX, Levine SC. Acoustic neuroma surgery: the results of hearing conservation surgery. Laryngoscope. 1987; 97: 785-789.
119. Shelton C, Brackmann DE, House WF Hitselberger WE. Middle fossa acoustic tumor surgery: results in 106 cases. Laryngoscope. 1989; 99: 405-408.
120. Smouha E, Toh E, Schaitkin BM. Surgical treatment of Bell's palsy: current attitudes. Laryngoscope. 2011; 121: 1965-1970.
121. Barr JS, Katz KA, Hazen A. Surgical management of facial nerve paralysis in the pediatric population. J Pediatr Surg. 2011; 46: 2168-2176.
122. Chen N, Zhou M, He L, Zhou D Li N. Acupuncture for Bell's palsy. Cochrane Database Syst Rev. 2010;(8):CD002914.
123. Cheng KJ. Neuroanatomical basis of acupuncture treatment for some common illnesses. Acupunct Med. 2009; 27: 61-64.
124. Zheng H, Li Y, Chen M. Evidence based acupuncture practice recommendations for peripheral facial paralysis. Am J Chin Med. 2009; 37: 35-43.
125. Kim JI, Lee MS, Choi TY, Lee H Kwon HJ. Acupuncture for Bell's palsy: a systematic review and meta-analysis. Chin J Integr Med. 2012; 18: 48-55.
126. Vickers A, Goyal N, Harland R Rees R. Do certain countries produce only positive results? A systematic review of controlled trials. Controlled Clin Trials. 1998; 19: 159-166.
127. Cumberworth A, Mabvuure NT, Norris JM Watts S. Is acupuncture beneficial in the treatment of Bell's palsy? Best evidence topic (BET). Int J Surg. 2012; 10: 310-312.
128. Zhang J, Shang H, Gao X Ernst E. Acupuncture-related adverse events: a systematic review of the Chinese literature. Bull World Health Organ. 2010; 88: 915C-921C.
129. Endres HG, Molsberger A, Lungenhausen M Trampisch HJ. An internal standard for verifying the accuracy of serious adverse event reporting: the example of an acupuncture study of 190,924 patients. Eur J Med Res. 2004; 9: 545-551.
130. Witt CM, Pach D, Brinkhaus B, et al. Safety of acupuncture: results of a prospective observational study with 229,230 patients and introduction of a medical information and consent form. Forsch Komplementmed. 2009; 16: 91-97.
131. Norheim AJ. Adverse effects of acupuncture: a study of the literature for the years 1981-1994. J Altern Complement Med. 1996; 2: 291-297.
132. White A, Hayhoe S, Hart A Ernst E. Adverse events following acupuncture: prospective survey of 32 000 consultations with doctors and physiotherapists. BMJ. 2001; 323: 485-486.
133. Macpherson H, Scullion A, Thomas KJ Walters S. Patient reports of adverse events associated with acupuncture treatment: a prospective national survey. Qual Saf Health Care. 2004; 13: 349-355.
134. Park SU, Ko CN, Bae HS, et al. Short-term reactions to acupuncture treatment and adverse events following acupuncture: a cross-sectional survey of patient reports in Korea. J Altern Complement Med. 2009; 15: 1275-1283.
135. Yamashita H, Tsukayama H, White AR, Tanno Y, Sugishita C Ernst E. Systematic review of adverse events following acupuncture: the Japanese literature. Complement Ther Med. 2001; 9: 98-104.
136. He W, Zhao X, Li Y, Xi Q Guo Y. Adverse events following acupuncture: a systematic review of the Chinese literature for the years 1956-2010. J Altern Complement Med. 2012; 18: 892-901.
137. White A. A cumulative review of the range and incidence of significant adverse events associated with acupuncture. Acupunct Med. 2004; 22: 122-133.
138. Pereira LM, Obara K, Dias JM, Menacho MO, Lavado EL Cardoso JR. Facial exercise therapy for facial palsy: systematic review and meta-analysis. Clin Rehabil. 2011; 25: 649-658.
139. Teixeira LJ, Valbuza JS, Prado GF. Physical therapy for Bell's palsy (idiopathic facial paralysis). Cochrane Database Syst Rev. 2011;(12):CD006283.
140. Beurskens CH, Heymans PG. Positive effects of mime therapy on sequelae of facial paralysis: stiffness, lip mobility, and social and physical aspects of facial disability. Otol Neurotol. 2003; 24: 677-681.
141. Beurskens CH, Heymans PG. Physiotherapy in patients with facial nerve paresis: description of outcomes. Am J Otolaryngol. 2004; 25: 394-400.
142. Beurskens CH, Heymans PG. Mime therapy improves facial symmetry in people with long-term facial nerve paresis: a randomised controlled trial. Aust J Physiother. 2006; 52: 177-183.
143. Beurskens CH, Heymans PG, Oostendorp RA. Stability of benefits of mime therapy in sequelae of facial nerve paresis during a 1-year period. Otol Neurotol. 2006; 27: 1037-1042.
144. Cardoso JR, Teixeira EC, Moreira MD, Favero FM, Fontes SV Bulle de Oliveira AS. Effects of exercises on Bell's palsy: systematic review of randomized controlled trials. Otol Neurotol. 2008; 29: 557-560.
145. Barbara M, Antonini G, Vestri A, Volpini L Monini S. Role of Kabat physical rehabilitation in Bell's palsy: a randomized trial. Acta Otolaryngol. 2010; 130: 167-172.
146. Manikandan N. Effect of facial neuromuscular re-education on facial symmetry in patients with Bell's palsy: a randomized controlled trial. Clin Rehabil. 2007; 21: 338-343.
147. Nakamura K, Toda N, Sakamaki K, Kashima K Takeda N. Biofeedback rehabilitation for prevention of synkinesis after facial palsy. Otolaryngol Head Neck Surg. 2003; 128: 539-543.
148. Coulson SE, O’Dwyer N J Adams RD Croxson GR. Expression of emotion and quality of life after facial nerve paralysis. Otol Neurotol. 2004; 25: 1014-1019.